NAD+

35 studies on NAD+ curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

2025-11-01 PubMed

Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.
2026-03-01 PubMed

Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.
2026-01-01 PubMed

The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans.
2026-03-31 PubMed

Metabolic reprogramming of neurons in alzheimer disease: a biochemical perspective.
2026-05-01 PubMed

Beyond disease treatment and prevention: From geroscience and molecular hallmarks to gerotherapeutics and precision geromedicine.
2026-05-01 PubMed

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.
2026-05-15 PubMed

Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial.
2026-01-01 PubMed

Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.
2026-05-23 PubMed

Regenerative Approaches to Enhance the Skin Microenvironment and Boost Aesthetic Efficacy: A Narrative Review.
2026-05-29 PubMed

Skin Cancer Prevention and Antiaging: Role of Nicotinamide.
2026-05-30 PubMed

Nutritional Regulation of Ovarian Bioenergetics: Implications for Reproductive Aging and Female Infertility.
2026-01-01 PubMed

Sex-specific differences in vascular circulation and metabolic regulation associated with aging and cardiovascular health problems.
2026-01-01 PubMed

Beyond cartilage degeneration: osteoarthritis as a systems failure of inflammation regulation.
2026-06-01 PubMed

Posttraumatic Stress Disorder (PTSD) NAD/Sirtuin Deficiency and SARM1-Mediated Synaptic Vulnerability: Evidence for Accelerated Brain Aging Subtypes.
2026-06-01 PubMed

Opposing Molecular Programs in Obsessive-Compulsive Disorder and Hoarding: Transcriptome-Wide Association Studies Reveal Distinct Senescence, Complement, and Metabolic Signatures.
2026-06-09 PubMed

Antiaging Effects of Mannose-6-Phosphate through Enhanced Mitochondrial Function and Collagen Remodeling.
2026-06-02 PubMed

Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness.
2026-01-01 PubMed

NMN protects vascular endothelial cells from M1 macrophage-derived IL-1β-induced hyperpermeability by inhibiting VE-cadherin degradation.
2026-06-11 PubMed

Restoration of mitochondrial dynamics and synaptic function by mitophagy enhancers in a tauopathy cell model.
2026-01-01 PubMed

Integrated transcriptomic and metabolomic identification of the core pathway of photosynthetic carbon fixation in mung bean under saline-alkali stress.
2026-01-01 PubMed

Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans.
2026-06-04 PubMed

Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren's disease.
2026-01-01 PubMed

[Sleep disorders and chronic cerebral ischemia].
2026-05-22 PubMed

Molecular Engineering of Nicotinamide Riboside Kinase and Process Optimization for Efficient Nicotinamide Mononucleotide Production.
2026-06-12 PubMed

Development of a Noncanonical Redox Cofactor Platform in Saccharomyces cerevisiae.
2026-01-01 PubMed

Preliminary exploration of acute limit toxicity testing for nicotinamide mononucleotide in the neonatal population.
2026-06-16 PubMed

Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.
2026-05-08 PubMed

A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.
2026-06-01 PubMed

Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice.
2026-10-01 PubMed

A sustained NAD+ supplementation-biosynthesis nanoplatform for metabolic restoration in aged bone regeneration.
2026-06-03 PubMed

Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
2026-01-01 PubMed

Niacinamide modulation by hemocyanin shapes hemolymph microbial communities in Penaeid shrimp.
2026-06-05 PubMed

DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment.
2026-01-01 PubMed

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities.
2026-06-15 PubMed

Sex Dimorphism of NAD+De Novo Biosynthesis Mediates Sex-Biased Susceptibility to Ischemia-Reperfusion-Induced Acute Kidney Injury.

Research tools

Free, no account — handy when you're working with NAD+.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age and enter your details to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.